- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00567853
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair (MEMO3D)
January 22, 2015 updated by: Sorin Group USA, Inc.
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
The purpose of this study is to collect data on the effectiveness and clinical outcomes of the MEMO 3D Annuloplasty ring as used for mitral valve repair.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
278
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2T9
- Foothills Medical Centre
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 3A7
- Queen Elizabeth II Health Sciences Centre
-
-
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Minneapolis Heart Institute
-
-
Missouri
-
St. Louis, Missouri, United States, 63100
- Barnes Jewish Hospital
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania Presbyterian Hospital
-
-
Texas
-
Plano, Texas, United States, 75093
- The Heart Hospital Baylor Plano
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subject is 18 years old or older
- An annuloplasty ring is indicated for reinforcement of a dysfunctional or diseased native mitral valve according to the current medical practice for valvular repair at each site.
- The subject is able to return for all follow-up evaluations of the study.
Exclusion Criteria:
- The subject or subject's legal representative is unwilling to sign the informed consent.
- The subject is or will be participating in another medical device or drug clinical trial.
- The subject is a minor, prisoner, institutionalized, or is unable to give informed consent.
- The subject has a life expectance of less than 1 year.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: MEMO 3D ring
All patients in the study will be implanted with the MEMO 3D ring
|
Implantation of the MEMO 3D Annulopalsty Ring for mitral valve repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The percentage of patients with successful repair at 6 months.
Time Frame: One Year
|
One Year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Freedom from re-operation at 12 months. Preoperative and postoperative mitral valve regurgitation and LV dimensions and mass assessed by echocardiography. Actuarial survival and freedom from clinical events at 12 months.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Clark Hargrove, M.D., University of Pennsylvania Presbyterian Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2007
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
December 4, 2007
First Submitted That Met QC Criteria
December 4, 2007
First Posted (Estimate)
December 5, 2007
Study Record Updates
Last Update Posted (Estimate)
January 26, 2015
Last Update Submitted That Met QC Criteria
January 22, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MEMO3D.Reg
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mitral Valve Regurgitation
-
Ancora Heart, Inc.CompletedMitral Regurgitation | Mitral Valve Regurgitation | Functional Mitral RegurgitationAustria, Lithuania, Germany
-
Heinrich-Heine University, DuesseldorfCompletedMitral Regurgitation | Functional Mitral Regurgitation | Degenerative Mitral Valve RegurgitationGermany
-
Abbott Medical DevicesCompletedMitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Functional Mitral Regurgitation | Mitral Stenosis With InsufficiencyJapan
-
Abbott Medical DevicesCompletedFunctional Mitral Regurgitation | Degenerrative Mitral RegurgitationRussian Federation
-
IRCCS Policlinico S. DonatoActive, not recruitingMitral RegurgitationItaly
-
Abbott Medical DevicesAbbottCompletedMitral Regurgitation | Mitral Valve RegurgitationJapan
-
Boston Scientific CorporationActive, not recruitingCardiovascular Diseases | Mitral Regurgitation Functional | Mitral Valve DiseaseUnited States, Australia
-
Abbott Medical DevicesAbbottActive, not recruitingMitral Regurgitation | Mitral Valve RegurgitationUnited States, Canada, Spain, Israel, Germany, Italy, Japan, France, Netherlands, Saudi Arabia
-
Duk-Woo Park, MDCardioVascular Research Foundation, KoreaCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve RegurgitationKorea, Republic of
-
Abbott Medical DevicesAbbottCompletedMitral Regurgitation | Mitral Valve RegurgitationNetherlands, United Kingdom, United States, Spain, Israel, Germany, Italy, Switzerland
Clinical Trials on Implantation of the MEMO 3D Annuloplasty Ring
-
University Hospital, GhentLivaNovaCompleted
-
Michele De BonisCompletedFunctional Tricuspid RegurgitationItaly
-
Medtronic Bakken Research CenterCompletedTricuspid Valve InsufficiencyFrance, Israel, Germany
-
Medtentia International Ltd OyTerminatedMitral Regurgitation | Mitral InsufficiencyFinland
-
Admedus Regen Pty Ltd.Factory CRO for Medical Devices B.V.RecruitingAortic Stenosis | Aortic InsufficiencyBelgium
-
Meshalkin Research Institute of Pathology of CirculationUnknownMitral Valve InsufficiencyRussian Federation
-
Peking University Third HospitalCompleted
-
Yonsei UniversityCompleted
-
Olympus Corporation of the AmericasInternational Urogynecology AssociatesCompletedPelvic Organ Prolapse | CystoceleUnited States
-
Edwards LifesciencesPacific Clinical Research GroupCompleted